GE HealthCare Technologies Inc. is a medical technology, pharmaceutical diagnostics, and digital solutions company. It develops, manufactures, and markets a portfolio of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients. Its segments include Imaging, Ultrasound, Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). Its Imaging segment offers a comprehensive portfolio of scanning devices, clinical applications, service capabilities, and digital solutions. Its Ultrasound segment includes ultrasound medical devices and solutions with a portfolio of continuum of care, including screening, diagnosis, treatment, and monitoring of certain diseases. Its PCS segment portfolio is comprised of patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, maternal infant care, and consumables and services. Its PDx segment is comprised of two business lines: contrast media and molecular imaging.

Employees

51,000

Sector

Advanced Medical Equipment & Technology

Calendar

2024-10-28 - Q3 2024 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
24-09-20	90.28 $	-0.38%	9,210,577
24-09-19	90.62 $	+2.36%	3,128,277
24-09-18	88.53 $	+2.00%	3,508,362
24-09-17	86.79 $	+0.17%	3,144,354
24-09-16	86.64 $	-0.31%	4,680,378

Delayed Quote Nasdaq, September 20, 2024 at 04:00 pm

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

90.62USD

Average target price

95.81USD

Spread / Average Target

+5.72%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Market Closed - Nasdaq Other stock markets 16:00:00 2024-09-20 EDT			5-day change	1st Jan Change
90.28 ^USD	-0.38%		+3.22%	+16.76%

09-19	GE HealthCare Introduces Elevated Venue Point of Care Ultrasound Solutions and New Tablet-Based Venue Sprint	CI
09-18	GE HealthCare Technologies Keeps Quarterly Dividend at $0.03 a Share, Payable Nov. 15 to Shareholders of Record Oct. 18	MT

Capitalization	41.38B 56.15B	P/E ratio 2024 *	22.8x	P/E ratio 2025 *	20x
Enterprise value	42.14B 57.18B	EV / Sales 2024 *	2.36x	EV / Sales 2025 *	2.14x
Free-Float	93.14%	Yield 2024 *	0.12%	Yield 2025 *	0.14%

GE HealthCare Introduces Elevated Venue Point of Care Ultrasound Solutions and New Tablet-Based Venue Sprint	09-19	CI
GE HealthCare Technologies Keeps Quarterly Dividend at $0.03 a Share, Payable Nov. 15 to Shareholders of Record Oct. 18	09-18	MT
GE HealthCare Technologies Inc. Announces Cash Dividend for Third Quarter of 2024, Payable on November 15, 2024	09-18	CI
BTIG Upgrades GE HealthCare Technologies to Buy From Neutral	09-18	MT
Health Care Up on Cyclical Bias -- Health Care Roundup	09-13	DJ
GE HealthCare Technologies Prices Upsized Secondary Public Offering	09-13	MT
GE HealthCare Launches Secondary Common Stock Offering	09-12	MT
JPMorgan Initiates GE HealthCare Technologies at Neutral With $90 Price Target	09-09	MT
GE HealthCare Technologies Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 01:05 PM	09-05
GE HealthCare Technologies Inc. Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 10:15 AM	09-04
Redburn Adjusts Price Target on GE HealthCare Technologies to $105 From $93, Maintains Buy Rating	09-03	MT
GE HealthCare Secures CE Marks for Cardiac Imaging Systems	08-26	MT
GE HealthCare: two technologies CE marked	08-26	CF

BTIG Upgrades GE HealthCare Technologies to Buy From Neutral	09-18	MT
JPMorgan Initiates GE HealthCare Technologies at Neutral With $90 Price Target	09-09	MT
Redburn Adjusts Price Target on GE HealthCare Technologies to $105 From $93, Maintains Buy Rating	09-03	MT
Stifel Initiates GE HealthCare Technologies at Buy With $100 Price Target	08-06	MT
Piper Sandler Adjusts Price Target on GE HealthCare Technologies to $95 From $92	08-01	MT

GE HealthCare Technologies Inc. Stock

Equities

GEHC

US36266G1076

Advanced Medical Equipment & Technology

Valuation: GE HealthCare Technologies Inc.

Chart: GE HealthCare Technologies Inc.

Latest news: GE HealthCare Technologies Inc.

Last Transcript: GE HealthCare Technologies Inc.

Analysts' recommendations: GE HealthCare Technologies Inc.

Press Releases: GE HealthCare Technologies Inc.

News in other languages: GE HealthCare Technologies Inc.

Quotes and Performance

Course Extremes

Managers and Directors: GE HealthCare Technologies Inc.

ETFs: GE HealthCare Technologies Inc.

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly earnings, Rate of surprise

GE HealthCare introduces elevated Venue point of care ultrasound solutions and new tablet-based Venue Sprint	09-19	BU
GE HealthCare announces cash dividend for third quarter of 2024	09-18	BU
GE HealthCare Technologies Inc. Prices Upsized Secondary Offering of 15,000,000 Shares	09-12	BU
GE HealthCare Technologies Inc. Commences Secondary Offering of 10,000,000 Shares	09-12	BU
GE HealthCare Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments at the Point of Care at ESC 2024	08-26	BU

GE HealthCare : obtient la marquage CE pour deux technologies	08-26
GE HealthCare aduce la debilidad del mercado chino para recortar las previsiones -- Market Talk	07-31
Schwaches China-Geschäft bremst Siemens Healthineers - Am Dax-Ende	07-31
GE HealthCare : hausse de 9% du BPA au 2e trimestre	07-31
Trop tôt pour se la couler douce en bourse	07-31

1 day	-0.38%
1 week	+3.22%
Current month	+6.44%
1 month	+5.48%
3 months	+15.34%
6 months	-0.55%
Current year	+16.76%

Director	Title	Age	Since
Peter Arduini CEO	Chief Executive Officer	59	22-12-13
James Saccaro DFI	Director of Finance/CFO	51	23-05-31
Jahid Khandaker CTO	Chief Tech/Sci/R&D Officer	-	22-09-30

Name	Weight	AuM	1st Jan change	Investor Rating
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - DIST - USD	0.07%	1,174 M€	+23.54%
LYXOR NET ZERO 2050 S&P 500 CLIMATE PAB (DR) UCITS ETF - ACC - USD	0.07%	655 M€	-.--%	-

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
GE HEALTHCARE TECHNOLOGIES INC.	-0.38%	+3.22%	+36.54%	-	41.38B
THERMO FISHER SCIENTIFIC INC.	-1.06%	-0.08%	+20.63%	+2.83%	237B
DANAHER CORPORATION	-1.37%	+0.05%	+6.82%	-15.99%	200B
INTUITIVE SURGICAL, INC.	-0.78%	-1.58%	+62.26%	+40.62%	174B
BOSTON SCIENTIFIC CORPORATION	+0.25%	+0.11%	+58.25%	+89.14%	123B
SIEMENS HEALTHINEERS AG	-3.39%	-3.82%	+7.73%	-17.96%	61.87B
AGILENT TECHNOLOGIES, INC.	-1.31%	+2.71%	+24.74%	-19.46%	40.79B
EDWARDS LIFESCIENCES CORPORATION	-0.64%	-1.91%	-8.48%	-44.04%	40.52B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-1.19%	-1.83%	-18.28%	-37.22%	39.46B
RESMED, INC.	+0.81%	-2.30%	+70.46%	-14.34%	35.7B
Average	-0.91%	+0.11%	+26.07%	-1.83%	99.37B
Weighted average by Cap.	-0.96%	+0.13%	+28.90%	+10.36%

	2024 *	2025 *
Net sales	19.79B 26.85B	20.81B 28.23B
Net income	1.81B 2.46B	2.08B 2.82B
Net Debt	5.38B 7.29B	3.21B 4.35B

Manager	Title	Age	Since
Peter Arduini CEO	Chief Executive Officer	59	22-12-13
Catherine Lesjak BRD	Director/Board Member	65	22-12-13
Rodney Hochman BRD	Director/Board Member	68	23-01-02